Fennec Announces Results of Annual Meeting

Rhea-AI Summary

On June 29, 2021, Fennec Pharmaceuticals announced the election of its management's proposed board nominees at the Annual General Meeting in Irvine, California. The results show strong shareholder support, with Dr. Khalid Islam receiving 99.05% approval and other nominees like Adrian Haigh and Chris A. Rallis also garnering over 97% support. Furthermore, 99.88% of shareholders approved the appointment of Haskell & White LLP as auditors, and 97.48% voted in favor of executive compensation. This indicates significant confidence from shareholders in the company's direction.

Positive

• Strong support for board nominees with votes exceeding 97% approval.
• 99.88% shareholder approval for auditor appointment.
• 97.48% approval for executive compensation.

Negative

• None.

RESEARCH TRIANGLE PARK, N.C., June 29, 2021 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated May 14, 2021 for the Annual General Meeting of Shareholders were elected as directors of the Company at the Annual General Meeting of Shareholders held in Irvine, California and online on June 29, 2021.

Detailed results of the vote for the election of directors are set out below:

Name of Nominee	Votes For	% Votes For		Votes Withheld	% Votes Withheld
Dr. Khalid Islam	13,646,934	99.05%		130,590	0.95%
Mr. Adrian Haigh	13,419,749	97.40%		357,775	2.60%
Mr. Chris A. Rallis	13,611,818	98.80%		165,706	1.20%
Dr. Marco Brughera	13,517,839	98.12%		259,685	1.88%
Dr. Jodi Cook	13,519,400	98.13%		258,124	1.87%
Mr. Rostislav Raykov	13,656,957	99.12%		120,567	0.88%

Shareholders also voted 99.88% in favour of appointing Haskell & White LLP as auditors and authorizing the directors to fix the auditor remuneration, and voted 97.48% in favour of the compensation paid to the Company’s named executive officers.

For further information, please contact:

Rosty Raykov
Chief Executive Officer
Fennec Pharmaceuticals Inc.
T: (919) 636-5144

FAQ

What were the voting results for the Fennec Pharmaceuticals board nominees?

The nominees received strong support, with votes for Dr. Khalid Islam at 99.05%, Adrian Haigh at 97.40%, and Chris A. Rallis at 98.80%. All nominees had over 97% approval.

When was the Fennec Pharmaceuticals Annual General Meeting held?

The Annual General Meeting was held on June 29, 2021.

What percentage of shareholders approved the auditor appointment for Fennec Pharmaceuticals?

99.88% of shareholders voted in favor of appointing Haskell & White LLP as auditors.

What percentage approved the compensation for Fennec Pharmaceuticals' executive officers?

97.48% of shareholders voted in favor of the compensation for the company's named executive officers.